vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Natera, Inc. (NTRA). Click either name above to swap in a different company.

APTARGROUP, INC. is the larger business by last-quarter revenue ($982.9M vs $665.5M, roughly 1.5× Natera, Inc.). APTARGROUP, INC. runs the higher net margin — 7.4% vs 7.1%, a 0.3% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 10.8%). APTARGROUP, INC. produced more free cash flow last quarter ($53.3M vs $37.8M). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 3.9%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

ATR vs NTRA — Head-to-Head

Bigger by revenue
ATR
ATR
1.5× larger
ATR
$982.9M
$665.5M
NTRA
Growing faster (revenue YoY)
NTRA
NTRA
+29.0% gap
NTRA
39.8%
10.8%
ATR
Higher net margin
ATR
ATR
0.3% more per $
ATR
7.4%
7.1%
NTRA
More free cash flow
ATR
ATR
$15.5M more FCF
ATR
$53.3M
$37.8M
NTRA
Faster 2-yr revenue CAGR
NTRA
NTRA
Annualised
NTRA
34.5%
3.9%
ATR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ATR
ATR
NTRA
NTRA
Revenue
$982.9M
$665.5M
Net Profit
$72.8M
$47.3M
Gross Margin
Operating Margin
10.9%
-3.4%
Net Margin
7.4%
7.1%
Revenue YoY
10.8%
39.8%
Net Profit YoY
-7.5%
187.9%
EPS (diluted)
$1.12
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
NTRA
NTRA
Q1 26
$982.9M
Q4 25
$962.7M
$665.5M
Q3 25
$961.1M
$592.2M
Q2 25
$966.0M
$546.6M
Q1 25
$887.3M
$501.8M
Q4 24
$848.1M
$476.1M
Q3 24
$909.3M
$439.8M
Q2 24
$910.1M
$413.4M
Net Profit
ATR
ATR
NTRA
NTRA
Q1 26
$72.8M
Q4 25
$74.3M
$47.3M
Q3 25
$127.9M
$-87.5M
Q2 25
$111.7M
$-100.9M
Q1 25
$78.8M
$-66.9M
Q4 24
$100.9M
$-53.8M
Q3 24
$100.0M
$-31.6M
Q2 24
$90.5M
$-37.5M
Operating Margin
ATR
ATR
NTRA
NTRA
Q1 26
10.9%
Q4 25
11.0%
-3.4%
Q3 25
14.2%
-16.5%
Q2 25
14.9%
-20.2%
Q1 25
12.8%
-15.8%
Q4 24
14.2%
-13.6%
Q3 24
15.2%
-8.9%
Q2 24
13.8%
-10.6%
Net Margin
ATR
ATR
NTRA
NTRA
Q1 26
7.4%
Q4 25
7.7%
7.1%
Q3 25
13.3%
-14.8%
Q2 25
11.6%
-18.5%
Q1 25
8.9%
-13.3%
Q4 24
11.9%
-11.3%
Q3 24
11.0%
-7.2%
Q2 24
9.9%
-9.1%
EPS (diluted)
ATR
ATR
NTRA
NTRA
Q1 26
$1.12
Q4 25
$1.13
$0.36
Q3 25
$1.92
$-0.64
Q2 25
$1.67
$-0.74
Q1 25
$1.17
$-0.50
Q4 24
$1.48
$-0.41
Q3 24
$1.48
$-0.26
Q2 24
$1.34
$-0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
NTRA
NTRA
Cash + ST InvestmentsLiquidity on hand
$229.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.6B
$1.7B
Total Assets
$5.1B
$2.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
NTRA
NTRA
Q1 26
$229.5M
Q4 25
$409.5M
Q3 25
$264.8M
$1.0M
Q2 25
$169.8M
$16.0M
Q1 25
$136.8M
$17.8M
Q4 24
$226.2M
$22.7M
Q3 24
$327.9M
$29.5M
Q2 24
$223.9M
$90.3M
Total Debt
ATR
ATR
NTRA
NTRA
Q1 26
Q4 25
$1.1B
Q3 25
$546.0M
Q2 25
$535.1M
Q1 25
$561.2M
Q4 24
$688.1M
Q3 24
$822.7M
Q2 24
$681.5M
Stockholders' Equity
ATR
ATR
NTRA
NTRA
Q1 26
$2.6B
Q4 25
$2.7B
$1.7B
Q3 25
$2.8B
$1.3B
Q2 25
$2.7B
$1.2B
Q1 25
$2.5B
$1.2B
Q4 24
$2.5B
$1.2B
Q3 24
$2.5B
$878.5M
Q2 24
$2.4B
$836.5M
Total Assets
ATR
ATR
NTRA
NTRA
Q1 26
$5.1B
Q4 25
$5.3B
$2.4B
Q3 25
$5.1B
$1.8B
Q2 25
$4.9B
$1.8B
Q1 25
$4.5B
$1.7B
Q4 24
$4.4B
$1.7B
Q3 24
$4.6B
$1.6B
Q2 24
$4.5B
$1.5B
Debt / Equity
ATR
ATR
NTRA
NTRA
Q1 26
Q4 25
0.43×
Q3 25
0.20×
Q2 25
0.20×
Q1 25
0.22×
Q4 24
0.28×
Q3 24
0.32×
Q2 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
NTRA
NTRA
Operating Cash FlowLast quarter
$73.9M
Free Cash FlowOCF − Capex
$53.3M
$37.8M
FCF MarginFCF / Revenue
5.4%
5.7%
Capex IntensityCapex / Revenue
6.7%
5.4%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$327.0M
$109.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
NTRA
NTRA
Q1 26
Q4 25
$183.7M
$73.9M
Q3 25
$177.6M
$59.4M
Q2 25
$126.0M
$37.6M
Q1 25
$82.7M
$44.5M
Q4 24
$178.2M
$52.9M
Q3 24
$229.3M
$51.8M
Q2 24
$143.6M
$4.0M
Free Cash Flow
ATR
ATR
NTRA
NTRA
Q1 26
$53.3M
Q4 25
$96.9M
$37.8M
Q3 25
$114.3M
$37.0M
Q2 25
$62.5M
$11.7M
Q1 25
$25.9M
$22.6M
Q4 24
$112.2M
$34.8M
Q3 24
$162.7M
$35.5M
Q2 24
$75.4M
$-7.7M
FCF Margin
ATR
ATR
NTRA
NTRA
Q1 26
5.4%
Q4 25
10.1%
5.7%
Q3 25
11.9%
6.2%
Q2 25
6.5%
2.1%
Q1 25
2.9%
4.5%
Q4 24
13.2%
7.3%
Q3 24
17.9%
8.1%
Q2 24
8.3%
-1.9%
Capex Intensity
ATR
ATR
NTRA
NTRA
Q1 26
6.7%
Q4 25
9.0%
5.4%
Q3 25
6.6%
3.8%
Q2 25
6.6%
4.7%
Q1 25
6.4%
4.3%
Q4 24
7.8%
3.8%
Q3 24
7.3%
3.7%
Q2 24
7.5%
2.8%
Cash Conversion
ATR
ATR
NTRA
NTRA
Q1 26
Q4 25
2.47×
1.56×
Q3 25
1.39×
Q2 25
1.13×
Q1 25
1.05×
Q4 24
1.77×
Q3 24
2.29×
Q2 24
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons